چکیده (انگلیسی):

y Objective: To compare the safety and efficacy of transurethral plasmakinetic
resection of the prostate (PKRP) versus transvesical prostatectomy (TVP) in the treatment of
large-volume benign prostatic hyperplasia (LV-BPH) (100e149 mL).
Methods: Ninety-nine BPH patients who had a prostate volume of 100e149 mL were divided
into two groups to undergo PKRP or TVP. Preoperative clinical data were analyzed. Patients
had follow-up appointments at 1 month, 3 months, 6 months, and 12 months postoperatively.
Outcome measures included the International Prostate Symptom Score, quality of life score,
maximum urinary flow rate, and postvoid residual urine volume. Adverse effects were also recorded.
Results: A total of 96 patients completed the 12-month follow-up. The operative time was
longer, but intraoperative blood loss was lower in the PKRP group. Despite a higher percentage
of patients requiring a blood transfusion, there was an obvious advantage in gland removal rate
in the TVP group. The duration of postoperative catheterization, bladder irrigation, and hospital
stay was significantly shorter in the PKRP group. Outcome measures were significantly
improved in both groups 1 month postoperatively. The improvement in lower urinary tract
symptoms was maintained throughout the 12 months after surgery. There were no significant
differences in International Prostate Symptom Score, quality of life, maximum urinary flow
rate, and postvoid residual urine volume between the two groups.
Conclusion: PKRP has the advantage over TVP of being minimally invasive in the treatment of
LV-BPH while achieving the same postoperative outcomes.